Table 2.
Medication, vascular access, and preoperative dialysis in 219 patients with ESRD
| Characteristic | Value, n (%) |
|---|---|
| Medication | |
| Aspirina | 164 (75) |
| LMWH | 27 (12) |
| Warfarin | 23 (11) |
| Clopidogrel | 14 (6) |
| Dipyridamole | 5 (2) |
| No antithrombotic medication | 27 (12) |
| Statin | 121 (55) |
| No dialysis | 121 (55) |
| Ongoing preoperative dialysis | 98 (45) |
| HD [duration >3 mo] | 93 (43) [30, 32%] |
| Peritoneal dialysis [duration >3 mo] | 5 (2) [5, 100%] |
| First access operation | 198 (90) |
| Anatomic location | |
| Radiocephalic (wrist) | 199 (91) |
| Brachiocephalic (elbow) | 20 (9) |
| Median access flow (range) (ml/min)b (n=209) | 180 (10–855) |
LMWH, low molecular-weight heparin; HD, hemodialysis.
a
For 30 patients, aspirin was initiated in association with the access surgery.
b
According to transient-time ultrasonography immediately after surgery.